fda compounding semaglutide warning letters september 2025 Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s FDA warns Ozempic and Mounjaro

This is significant because it may allow an additional reduction in liver fat, potentially helping to reduce liver inflammation and fibrosis, two causes of obesity-related complications

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in specific patient populations

You see patients who tolerated the medicine perfectly but never adjusted what was on their plate, so the weight crept back the moment the prescription ran out

However, the timing can significantly influence your subjective experience, particularly regarding side effects like fatigue or indigestion

What You May Notice Over Time Weeks 1 to 2: You may start to feel full sooner and think about food less often Weeks 2 to 4: Cravings may feel less intense and meals may start to feel easier to manage Weeks 4 to 8: Some people begin to notice gradual weight loss, along with steadier energy or better control of eating After 8 weeks: Weight loss may become more noticeable as healthy habits and treatment start working together

We focus on the off-ramp strategy